Login
Subscribe
Quest for Research Freedom Fuels African Biotech Boom
Quest for Research Freedom Fuels African Biotech Boom
Tired of dancing to the tunes of international funders, and doubtful that long-promised national grants will come, a handful of African biomedical scientists have turned to private investors to bankroll their dreams of autonomy in the lab.
Tired of dancing to the tunes of international funders, and doubtful that long-promised national grants will come, a handful of African biomedical scientists have turned to private investors to bankroll their dreams of autonomy in the lab.
drug development, biobusiness, industry
Drug Approval Timeline Same as 20 Years Ago
Kerry Grens | Jan 9, 2017 | 2 min read
A report finds that new medications still take about 12 years to go from patent to patient.
Q&A: From FDA to Industry
Kerry Grens | Sep 27, 2016 | 5 min read
Among a subset of US Food and Drug Administration regulators who leave the agency, more than half go to work for pharmaceutical companies, researchers report.
Treating Toxoplasmosis
Jef Akst | Sep 25, 2015 | 2 min read
While one company hikes the price of an old drug to treat the parasitic infection, academic researchers report that an approved blood pressure medication could be just what the doctor ordered.
23andMe Enters Drug Development
Kerry Grens | Mar 12, 2015 | 2 min read
The personal genomics firm announces plans to make medicines.
LabCorp Buys CRO
Kerry Grens | Nov 4, 2014 | 1 min read
The $6 billion deal marks yet another massive transaction in the health-care industry.
Incubator Boom
Kerry Grens | Mar 1, 2014 | 7 min read
From San Francisco to St. Louis, biotech incubators are proliferating across North America. Can they deliver on their promise of fueling the economy?